South America Pharmaceutical Intermediates Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (GMP and Non GMP), Application (Antibiotics, Antipyretic Analgesics, Vitamins, and Others), and Distribution Channel (Distributor and Direct Sales)
Market Introduction
South America (SAM) region consists of Brazil, Argentina, and Rest of South America. The countries are likely to offer growth opportunities due to growing domestic’s production of pharmaceutical and biopharmaceutical production, increasing support from governments, and rising research and developments. Brazil’s 70% of pharmaceutical business is dependent on imports of pharmaceutical products. For instance, in 2019, medicines worth US$ 7 billion were imported, among which biological medicines were worth US$ 2 billion, i.e., 30% of the total import. However, the COVID-19 pandemic has offered vital growth opportunities for the domestic production of medicines to Brazil and various countries across the world. Associations in Brazil such as the Brazilian Association of Generic Medicines Industries (PróGenlicos) and FarmaBrasil Group (GFB) state that the country can produce nearly 75% of the total demand for medicines in the country. Therefore, it is expected to increase the demand for pharmaceutical intermediates in the country. Also, in 2019, the country has imported a significant number of biological products or immunotherapeutic drugs worth US$ 1 billion. Therefore, it is expected that investing a huge amount in importing pharmaceutical products. The country can invest in the domestic production of medicines and will only incur in importing pharmaceutical intermediates. In addition, the companies operating in the country that are associated with FarmaBrasil Group have commitments, through the Partnerships for Productive Development (PDPs), to produce medicines domestically, including bevacizumab, palivizumab, infliximab, betainterferone 1A, and insulin, among others. Thus, it is expected that such strategic moves for domestic production will enhance the demand for pharmaceutical intermediate and eventually lead to market growth in the following years. Rise in prevalence of chronic diseases and infectious diseases is the major factor driving the growth of the SAM pharmaceutical intermediates market.
The South America region includes countries such as Brazil and Argentina. These countries have also registered a significant number of positive coronavirus infection cases. In the South American region, the virus continues to spread aggressively in Brazil, Peru, and Chile. Many South American countries have faced shortages of resources to manufacture and supply medical products. Some of the hard-hit countries such as Brazil, where case number surpassed 13,521,409, and Argentina, the case recorded as 2,551,999 as of April 2021. It is expected that the region is likely to impose a second lockdown, which will eventually hamper the healthcare industry in the area. COVID-19 continues to have a tremendous impact on the region. Although Peru established one of the strictest lockdowns in the South America region, it suffered the highest mortality rate due to COVID-19. The coronavirus pandemic has become an enormous challenge to this region, as they are low-cost regions. The Brazilian pharmaceutical industry is facing challenges of trying to contain the COVID-19 pandemic while dealing with enormous cost pressures. In Brazil, the rise in the dollar has made importing APIs more expensive and also there is increase in logistics costs, due to the reduction in air traffic, with the consequent upsurge in freight costs. Additionally, there is also significant increase in the prices of raw materials, inputs and finished products. These factors are likely to have negative impact on the market.
Get more information on this report :
Market Overview and Dynamics
The pharmaceutical intermediates market in SAM is expected to grow from US$ 997.56 million in 2021 to US$ 1,197.02 million by 2028; it is estimated to grow at a CAGR of 2.6% from 2021 to 2028. Countries such as Argentina and Chile are emerging as attractive outsourcing locations for pharmaceuticals and biopharmaceuticals industries. Low manufacturing and operating costs in these countries are key factors driving the pharmaceutical manufacturing business in the region. Recent growth in the pharmaceutical industry indicate a positive outlook for the pharmaceutical intermediates market. Flourishing domestic pharmaceutical market in the region and increasing number of pipeline drugs are further opening new avenues for the contract manufacturers as well as generic drug manufacturing in the region. Additionally, to meet the growing demand, many contract-based organizations are expanding their manufacturing capabilities, further boosting the growth of the market. Thus, the emerging markets hold high potential and huge revenue generation opportunities for the pharmaceutical manufacturing companies across SAM region.
Key Market Segments
The SAM pharmaceutical intermediates market is segmented on the bases of type, application, distribution channel, and country. Based on type, the market is segmented into GMP and Non GMP. The GMP segment dominated the market in 2020 is expected to be the fastest growing during the forecast period. On the basis of application, the pharmaceutical intermediates market is segmented into antibiotics, antipyretic analgesics, vitamins, and others. The others segment dominated the market in 2020 and vitamins segment is expected to be the fastest growing during the forecast period. On the basis of distribution channel, the pharmaceutical intermediates market is segmented into distributor and direct sales. The direct sales segment dominated the market in 2020 and distributor segment is expected to be the fastest growing during the forecast period.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the pharmaceutical intermediates market in SAM are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are BASF SE; chiracon GmbH; Codexis; Dishman Carbogen Amcis Ltd; Midas Pharma GmbH; Pfizer Inc.; and Sanofi are among others.
Reasons to buy report
- To understand the SAM pharmaceutical intermediates market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for SAM pharmaceutical intermediates market
- Efficiently plan M&A and partnership deals in SAM pharmaceutical intermediates market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form SAM pharmaceutical intermediates market
- Obtain market revenue forecast for market by various segments from 2021-2028 in SAM region.
SAM Pharmaceutical Intermediates Market Segmentation
SAM Pharmaceutical Intermediates Market -By Type
- GMP
- Non GMP
SAM Pharmaceutical Intermediates Market -By Application
- Antibiotics
- Antipyretic analgesics
- Vitamins
- Others
SAM Pharmaceutical Intermediates Market -By Distribution Channel
- Distributor
- Direct Sales
SAM Pharmaceutical Intermediates Market -By Country
- Brazil
- Argentina
- Rest of SAM
SAM Pharmaceutical Intermediates Market -Company Profiles
- BASF SE
- chiracon GmbH
- Codexis
- Dishman Carbogen Amcis Ltd
- Midas Pharma GmbH
- Pfizer Inc.
- Sanofi
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 SAM Pharmaceutical Intermediates Market – By Type
1.3.2 SAM Pharmaceutical Intermediates Market – By Application
1.3.3 SAM Pharmaceutical Intermediates Market – By Distribution Channel
1.3.4 SAM Pharmaceutical Intermediates Market– By Country
2. SAM Pharmaceutical Intermediates Market– Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SAM Pharmaceutical Intermediates Market– Market Landscape
4.1 Overview
4.2 SAM PEST Analysis
4.3 Expert Opinion
5. SAM Pharmaceutical Intermediates Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rise in Prevalence of Chronic Diseases and Infectious Diseases
5.1.2 Escalating R&D Investments by Pharmaceutical Companies
5.2 Market Restraints
5.2.1 High Cost of Manufacturing
5.3 Market Opportunities
5.3.1 Developing Markets
5.4 Future Trends
5.4.1 Increasing Adoption of AI-based Tools for Drug Discovery
5.5 Impact Analysis
6. Pharmaceutical Intermediates Market– SAM Analysis
6.1 SAM Pharmaceutical Intermediates Market Revenue Forecast and Analysis
7. SAM Pharmaceutical Intermediates Market Analysis – By Type
7.1 Overview
7.2 Pharmaceutical Intermediates Market Revenue Share, by Type (2020 and 2028)
7.3 GMP
7.3.1 Overview
7.3.2 GMP: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
7.4 Non GMP
7.4.1 Overview
7.4.2 Non GMP: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
8. SAM Pharmaceutical Intermediates Market Analysis – By Application
8.1 Overview
8.2 Pharmaceutical Intermediates Market Revenue Share, by Application (2020 and 2028)
8.3 Antibiotics
8.3.1 Overview
8.3.2 Antibiotics: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
8.4 Antipyretic Analgesics
8.4.1 Overview
8.4.2 Antipyretic Analgesics: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
8.5 Vitamins
8.5.1 Overview
8.5.2 Vitamins: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
8.6 Other
8.6.1 Overview
8.6.2 Other: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
9. SAM Pharmaceutical Intermediates Market– By Distribution Channel
9.1 Overview
9.2 Pharmaceutical Intermediates Market, by Distribution Channel, 2020 and 2028 (%)
9.3 Distributor
9.3.1 Overview
9.3.2 Distributor: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
9.4 Direct Sales
9.4.1 Overview
9.4.2 Direct Sales: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
10. SAM Pharmaceutical Intermediates Market – Country Analysis
10.1.1 South America: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)
10.1.2 Brazil: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1 Brazil: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2 Brazil: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)
10.1.2.3 Brazil: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)
10.1.2.4 Brazil: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.3 Argentina: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.1.3.1 Argentina: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.1.3.2 Argentina: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)
10.1.3.3 Argentina: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)
10.1.3.4 Argentina: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.4 Rest of South America: Pharmaceutical Intermediates Market- Revenue and Forecasts to 2028 (USD Million)
10.1.4.1 Rest of South America: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.1.4.2 Rest of South America: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)
10.1.4.3 Rest of South America: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)
10.1.4.4 Rest of South America: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)
11. Impact of COVID-19 Pandemic on SAM Pharmaceutical Intermediates Market
12. SAM Pharmaceutical Intermediates Market– Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Pfizer Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Sanofi
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 BASF SE
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Dishman Carbogen Amcis Ltd
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Codexis
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Midas Pharma GmbH
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 chiracon GmbH
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. SAM Pharmaceutical Intermediates Market Revenue and Forecast to 2028 (US$ Million)
Table 2. Brazil Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 3. Brazil Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 4. Brazil Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 5. Argentina Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 6. Argentina Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 7. Argentina Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 8. Rest of South America Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 9. Rest of South America Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 10. Rest of South America Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 11. Organic Developments Done By Companies
Table 12. Inorganic Developments Done By Companies
Table 13. Glossary of Terms, SAM Pharmaceutical Intermediates Market
LIST OF FIGURES
Figure 1. SAM Pharmaceutical Intermediates Market Segmentation
Figure 2. SAM Pharmaceutical Intermediates Segmentation, By Country
Figure 3. SAM Pharmaceutical Intermediates Market Overview
Figure 4. GMP Held Largest Share of Type Segment in SAM Pharmaceutical Intermediates Market
Figure 5. Brazil to Show Remarkable Growth During Forecast Period
Figure 6. SAM: PEST Analysis
Figure 7. Expert Opinion
Figure 8. SAM Pharmaceutical Intermediates Market Impact Analysis of Driver and Restraints
Figure 9. SAM Pharmaceutical Intermediates Market– Revenue Forecast and Analysis – 2019- 2028
Figure 10. SAM Pharmaceutical Intermediates Market Revenue Share, by Type (2020 and 2028)
Figure 11. SAM GMP: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
Figure 12. SAM Non GMP Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
Figure 13. SAM Pharmaceutical Intermediates Market Revenue Share, by Application (2020 and 2028)
Figure 14. SAM Antibiotics: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
Figure 15. SAM Antipyretic Analgesics: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
Figure 16. SAM Vitamins: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
Figure 17. SAM Other: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
Figure 18. SAM Pharmaceutical Intermediates Market, by Distribution Channel, 2020 and 2028 (%)
Figure 19. SAM Distributor: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
Figure 20. SAM Direct Sales: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
Figure 21. South America: Pharmaceutical Intermediates Market, by Key Country – Revenue (2020) (USD Million)
Figure 22. South America: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)
Figure 23. Brazil: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
Figure 24. Argentina: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
Figure 25. Rest of South America: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
Figure 26. Impact of COVID-19 Pandemic in SAM Market
- BASF SE
- chiracon GmbH
- Codexis
- Dishman Carbogen Amcis Ltd
- Midas Pharma GmbH
- Pfizer Inc.
- Sanofi
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the SAM Pharmaceutical Intermediates market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the SAM Pharmaceutical Intermediates market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth SAM market trends and outlook coupled with the factors driving the Pharmaceutical Intermediates market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution